Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.

scientific article published on 19 December 2016

Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/RHEUMATOLOGY/KEW436
P932PMC publication ID5850788
P698PubMed publication ID27994093

P2093author name stringJeremy Sokolove
Justyna Fert-Bober
William H Robinson
Joao Lima
Joan M Bathon
Jon T Giles
Cesare Russo
Afshin Zartoshti
Laura Geraldino-Pardilla
Jenny Van Eyk
P2860cites workAdvances in the epidemiology of heart failure and left ventricular remodelingQ26827147
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisQ27860872
Proteomics of citrullination in cardiovascular diseaseQ28242377
Citrullination of myofilament proteins in heart failureQ30670009
Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritisQ34290839
Increased left ventricular mass as a predictor of sudden cardiac death: is it time to put it to the test?Q34328677
Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imagingQ34433298
Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritisQ35036976
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.Q35691658
Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors and mortalityQ35954706
Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.Q36085051
Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery AtherosclerosisQ36403294
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritisQ37270792
Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritisQ37715460
Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic reviewQ38045857
Baseline and long-term fibrinogen levels and risk of sudden cardiac death: A new prospective study and meta-analysisQ38685194
Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.Q52989369
The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 yearsQ57540261
The heart in rheumatoid arthritis (rheumatoid disease). A clinical and pathological study of sixty-two casesQ79439717
Association study between fibronectin and coronary heart diseaseQ82072819
P433issue4
P304page(s)534-540
P577publication date2017-04-01
P1433published inRheumatologyQ7320492
P1476titleAssociation of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.
P478volume56

Reverse relations

cites work (P2860)
Q92104941Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
Q52312175Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.
Q58804181Potential Impact of Oral Inflammations on Cardiac Functions and Atrial Fibrillation
Q88487488Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome: Where There Is a Will, There Is a Way
Q57267856Progress on Identifying and Characterizing the Human Proteome: 2018 Metrics from the HUPO Human Proteome Project
Q89477236Roles of Oral Infections in the Pathomechanism of Atherosclerosis

Search more.